Laboratorios Farmaceuticos Rovi, S.A.
LABFF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $75,696 | $26,777 | $22,849 | $32,193 |
| Dep. & Amort. | $7,469 | $7,467 | $7,281 | $7,427 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | -$36,578 | -$10,134 | -$2,439 | $73,143 |
| Other Non-Cash | $26,786 | -$14,930 | -$8,847 | -$39,641 |
| Operating Cash Flow | $73,373 | $9,180 | $18,844 | $73,122 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$16,991 | -$12,102 | -$8,057 | -$29,442 |
| Net Acquisitions | $0 | $0 | -$3,463 | -$18,835 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$547 | -$279 | -$74 | $1,103 |
| Investing Cash Flow | -$17,538 | -$12,381 | -$11,594 | -$47,174 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$5,768 | $20,163 | -$6,216 | -$15,634 |
| Stock Issued | $16,386 | $13,913 | $14,451 | $18,993 |
| Stock Repurch. | -$16,388 | -$13,694 | -$14,686 | -$19,036 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$46,929 | -$573 | -$543 | -$639 |
| Financing Cash Flow | -$52,699 | $19,809 | -$6,994 | -$16,316 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $3,136 | $16,808 | $2,120 | $9,632 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $46,114 | $29,306 | $27,186 | $17,554 |
| End Cash | $49,250 | $46,114 | $29,306 | $27,186 |
| Free Cash Flow | $55,751 | -$3,383 | $10,569 | $44,730 |